Combined positive/negative purging and transplantation of peripheral blood progenitor cell autografts in breast cancer patients: A pilot study

Experimental Hematology

Volumn 27, Issue 1, 1999, Pages 169-175

  Mapara, Markus Y ^a   Körner, Ida J ^a   Lentzsch, Suzanne ^a   Krahl, Dorothea ^a   Reichardt, Peter ^a   Dörken, Bernd ^a  

^a HUMBOLDT UNIVERSITY   (Germany)

Author keywords

Breast cancer; CD34+ selection; Negative selection; Positive selection; Purging

Indexed keywords

ETOPOSIDE; IFOSFAMIDE; MELPHALAN;

ADULT; ARTICLE; AUTOGRAFT; BONE MARROW PURGING; BREAST CANCER; CANCER COMBINATION CHEMOTHERAPY; CANCER STAGING; CLINICAL ARTICLE; HUMAN; LEUKAPHERESIS; PERIPHERAL BLOOD STEM CELL; PILOT STUDY; PRIORITY JOURNAL; STEM CELL TRANSPLANTATION; TREATMENT OUTCOME;

ADULT; ANTIGENS, CD34; BREAST NEOPLASMS; FEASIBILITY STUDIES; FEMALE; GRAFT SURVIVAL; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; IMMUNOHISTOCHEMISTRY; IMMUNOMAGNETIC SEPARATION; LEUKAPHERESIS; LEUKOCYTE COUNT; LEUKOCYTES, MONONUCLEAR; MIDDLE AGED; PILOT PROJECTS; TRANSPLANTATION, AUTOLOGOUS;

EID: 0344791636     PISSN: 0301472X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0301-472X(98)00067-8     Document Type: Article

References (33)

1. Diel I.J., Kaufmann M., Goerner R., Costa S.D., Kaul S., Baster G. Detection of tumor cells in bone marrow of patients with primary breast cancer. a prognostic factor for distant metastasis J Clin Oncol. 10:1992;1534.
2. Brugger W., Bross K.J., Glatt M., Weber F., Mertelsmann R., Kanz L. Mobilization of tumor cells and hematopoietic progenitor cells into peripheral blood of patients with solid tumors. Blood. 833:1994;636.
3. Schulze R., Schulze M., Wischnik A., Ehnle S., Doukas K., Behr W., Ehret W., Schlimok G. Tumor cell contamination of peripheral blood stem cell transplants and bone marrow in high-risk breast cancer patients. Bone Marrow Transplant. 19:1997;1223.
4. Passos C.J., Ross A.A., Kahn D.J., Moss T.J., Davis J.M., Huelskamp A.M., Noga S.J., Davidson S.J., Kennedy M.J. Similar breast cancer cell contamination of single-day peripheral-blood progenitor-cell collections obtained after priming with hematopoietic growth factor alone or after cyclophosphamide followed by growth factor. J Clin Oncol. 14:1996;2569.
5. Passos C.J., Ross A.A., Moss T.J., Davis JM Huelskamp AM, Noga SJ, Davidson NE, Kennedy MJ Absence of breast cancer cells in a single-day peripheral blood progenitor cell collection after priming with cyclophosphamide and granulocyte-macrophage colony-stimulating factor. Blood. 85:1995;1138.
6. Gribben J.G., Arnold M.D., Freedman M.D., Neuberg D., Roy D.C., Blake K., Woo S.D., Grossbard M.L., Rabinowe S.N., Coral F., Freeman G.J., Ritz J., Nadler L.M. Immunologic purging of marrow assessed before autologous bone marrow transplantation for B cell lymphoma. N Engl J Med. 325:1991;1525.
7. Sharp J.G., Kessinger A., Mann S., Crouse D.A., Armitage J.O., Biermann P., Weisenburger D.D. Outcome of high-dose therapy and autologous transplantation in non-hodgkin's lymphoma based on the presence of tumor in the marrow or infused hematopoietic harvest. J Clin Oncol. 14:1996;214.
8. Brenner M.K., Rill D.R., Moen R.C., Krance R.A., Mirro J., Anderson W.F., Ihle J.N. Gene-marking to trace origin of relapse after autologous bone marrow transplantation. Lancet. 341:1993;85.
9. Rill D.R., Santana V.M., Roberts W.M., Nilson T., Bowman L.C., Krance R.A., Heslop H.E., Moen R.C., Ihle J.N., Brenner M.K. Direct demonstration that autologous bone marrow transplantation for solid tumors can return a multiplicity of tumorigenic cells. Blood. 84:1994;380.
10. Bregni M., Siena S., Formosa A., Lappi D.A., Martineau D., Malavasi F., Dörken G., Bonadonna G., Gianni A.M. B cell restricted saporin immunotoxins. activity against B cell lines and chronic lymphocytic leukemia cells Blood. 73:1989;753.
11. Kiesel S., Haas R., Moldenhauer G., Kvalheim G., Pezzutto A., Dörken B. Removal of cells from a malignant B cell line from bone marrow with immunomagnetic beads and with complement and immunoglobulin switch variant mediated cytolysis. Leuk Res. 11:1987;1119.
12. Santos G.W., Colvin M. Pharmacological purging of bone marrow with reference to autografting. Clin Haematol. 15:1986;67.
13. Shpall E.J., Jones R.B., Bearman S.I., Franklin W.A., Archer P.G., Curiel T., Bitter M., Claman H.N., Stemmer S.M., Purdy M., Myers S.E., Taffs S., Heimfeld S., Hallagan J., Berenson R.J. Transplantation of enriched CD34-positive autologous marrow into breast cancer patients following high-dose chemotherapy. influence of CD34-positive peripheral blood progenitors and growth factors on engraftment J Clin Oncol. 12:1994;28.
14. Barnoud R., Arvieux C., Pasquier D., Pasquier B., Letoublon C. Solitary fibrous tumour of the liver with CD34 expression. Histopathology. 28:1996;551.
15. Kimlinger T., Witzig T.E. Expression of the hematopoietic stem cell antigen CD34 on blood and bone marrow monoclonal plasma cells from patients with multiple myeloma. Bone Marrow Transplant. 19:1997;553.
16. Minderman H., Vanhoefer U., Toth K., Minderman M.D., Rustum Y.M. A unique human ovarian carcinoma cell line expressing CD34 in association with selection for multidrug resistance. Cancer. 78:1996;2427.
17. Cohen P.R., Rapini R.P., Farhood A.I. CD34 expression in neural and fibrohistiocytic lesions [letter; comment]. Am J Surg Pathol. 19:1995;115.
18. Mapara M.Y., Körner I.J., Hildebrandt M., Bargou R., Krahl D., Reichardt P., Dörken B. Monitoring of tumor cell purging after highly efficient immunomagnetic selection of CD34 cells from leukapheresis products in breast cancer patients. comparison of immunocytochemical tumor cell staining and RT-PCR Blood. 89:1997;337.
19. Dreger P., Viehmann K., Steinmann J., Eckstein V., Müller-Ruchholtz W., Löffler H., Schmitz N. G-CSF-mobilized peripheral blood progenitor cells for allogeneic transplantation. comparison of T cell depletion strategies using different CD34+ selection systems or CAMPATH-1 Exp Hematol. 23:1995;147.
20. Lane T.A., Law P., Maruyama M., Young D., Burgess J., Mullen M., Mealiffe M., Terstappen L.W.M.M., Hardwick A., Moubayed M., Oldham F., Corringham R.E.T., Ho A.D. Harvesting and enrichment of hematopoietic progenitor cells mobilized into the peripheral blood of normal donors by granulocyte macrophage colony stimulating factor (gm csp) or g csf. potential role in allogeneic marrow transplantation Blood. 85:1995;275.
21. Frankel A.E., Ring D.B., Tringale F., Hsieh M.S. Tissue distribution of breast cancer-associated antigens defined by monoclonal antibodies. J Biol Response Mod. 4:1985;273.
22. Ring D.B., Kassel J.A., Hsieh M.S., Bjorn M.J., Tringale F., Eaton A.M., Reid S.A., Frankel A.E., Nadji M. Distribution and physical properties of BCA200, a Mr 200,000 glycoprotein selectively associated with human breast cancer. Cancer Res. 49:1989;3070.
23. Ross A.A., Loudovaris M., Hazelton B., Weaver C.H., Schwartzberg L., Bender J.G. Immunocytochemical analysis of tumor cells in pre- and post-culture peripheral blood progenitor cell collections from breast cancer patients. Exp Hematol. 23:1995;1478.
24. Ross A.A., Cooper B.W., Lazarus H.M., Mackay W., Moss T.J., Ciobanu N., Tallman M.S., Kennedy M.J., Davidson N.E., Sweet D.et al. Detection and viability of tumor cells in peripheral blood stem cell collections from breast cancer patients using immunocytochemical and clonogenic assay techniques [see comments]. Blood. 82:1993;2605.
25. Moss T.J., Ross A.A. The risk of tumor cell contamination in peripheral blood stem cell collections. J Hematother. 1:1992;225.
26. Negrin R., Kusnierz-Glaz C., Still B., Schriber J., Chao N., Long G., Hoyle C., Hu W., Horning S., Brown B., Blume K., Strober S. Transplantation of enriched and purged peripheral blood progenitor cells from a single apheresis product in patients with non-Hodgkin's lymphoma. Blood. 85:1995;3334.
27. Lemoli R.M., Tazzari P.L., Fortuna A., Bolognesi A., Gulati S.C., Stirpe F., Tura S. Positive selection of hematopoietic CD34+ stem cells provides 'indirect purging' of CD34- lymphoid cells and the purging efficiency is increased by anti-CD2 and anti-CD30 immunotoxins. Bone Marrow Transplant. 13:1994;465.
28. Nimgaonkar M., Kemp A., Lancia J., Ball E.D. A combination of CD34 selection and complement-mediated immunopurgin (anti-CD15 monoclonal antibody) eliminates tumor cells while sparing normal progenitor cells. J Hematother. 5:1996;39.
29. Mapara M., Körner I., Hildebarndt M., Bargou R., Dörken B. Combined positive and negative purging of peripheral blood stem cell autografts in breast cancer patients (abstract). Blood. 88(suppl. 1):1996;251a.
30. Paulus U., Schmitz N., Viehmann K., von Neuhoff N., Dreger P. Combined positive/negative selection for highly effective purging of PBPC grafts. towards clinical application in patients with B-CLL Bone Marrow Transplant. 20:1997;415.
31. Bertolini F., Thomas T., Battaglia M., Gibelli N., Pedrazzoli P., Robustelli D.C.G. A new 'two step' procedure for 4.5 log depletion of T and B cells in allogeneic transplantation and of neoplastic cells in autologous transplantation. Bone Marrow Transplant. 19:1997;615.
32. Wolff G., Körner I.J., Schumacher A., Arnold A., Dörken B., Mapara M.Y. Ex vivo breast cancer cell purging by adenovirus-mediated cytosine deaminase gene transfer and short-term incubation with 5-fluorocytosine completely prevents tumor growth after transplantation. Human Gene Therapy. 9:1998;2277.
33. Vredenburgh J.J., Peters W.P., Rosner G., DeSombre K., Johnston W.W., Kamel A., Wu K., Bast R.J. Detection of tumor cells in the bone marrow of stage IV breast cancer patients receiving high-dose chemotherapy. the role of induction chemotherapy Bone Marrow Transplant. 16:1995;815.